Antara Capital LP Bausch Health Companies Inc. Call Options Transaction History

Antara Capital LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $10.1 Million - $20.3 Million	2,200,000 New	2,200,000 $15.2 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $7.06 Million - $23.6 Million	-1,000,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $13 Million - $16.7 Million	600,000 Added 150.0%	1,000,000 $22.9 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $9.2 Million - $11.6 Million	400,000 New	400,000 $11 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $12.5 Million - $15 Million	-500,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $13.7 Million - $16.4 Million	500,000 New	500,000 $14.7 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Antara Capital LP, based on Form 13F filings with the SEC.

Stay updated on Antara Capital LP with notifications on news.